NYSE:PBH - Prestige Brands Stock Price, Price Target & More

Prestige Brands trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Prestige Brands Holdings, Inc. (NYSE:PBH) posted its quarterly earnings data on Thursday, May, 10th. The company reported $0.62 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.61 by $0.01. The company had revenue of $256 million for the quarter, compared to analyst estimates of $255.61 million. Prestige Brands had a net margin of 32.61% and a return on equity of 13.33%. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.54 EPS. View Prestige Brands' Earnings History.

Prestige Brands is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Prestige Brands.

Prestige Brands updated its FY19 earnings guidance on Thursday, May, 10th. The company provided earnings per share (EPS) guidance of $2.96-3.04 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.03. The company issued revenue guidance of $1.046-1.056 billion, compared to the consensus revenue estimate of $1.06 billion.

6 Wall Street analysts have issued twelve-month price objectives for Prestige Brands' stock. Their predictions range from $33.00 to $125.00. On average, they anticipate Prestige Brands' stock price to reach $73.80 in the next twelve months. This suggests a possible upside of 100.4% from the stock's current price. View Analyst Ratings for Prestige Brands.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Brands in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Prestige Brands include SAGE Therapeutics (SAGE), Alkermes (ALKS), Catalent (CTLT), Ionis Pharmaceuticals (IONS), United Therapeutics (UTHR), FibroGen (FGEN), Loxo Oncology (LOXO), GALAPAGOS NV/S (GLPG), Agios Pharmaceuticals (AGIO), Ligand Pharmaceuticals (LGND), Dr.Reddy's Laboratories (RDY), Taro Pharmaceutical Industries (TARO), HUTCHISON CHINA/S (HCM), Ultragenyx Pharmaceutical (RARE) and GW Pharmaceuticals (GWPH).

Media coverage about PBH stock has trended somewhat positive on Saturday, according to Accern. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Prestige Brands earned a news impact score of 0.00 on Accern's scale. They also gave headlines about the company an impact score of 44.73 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Prestige Brands' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (2.62%), Municipal Employees Retirement System of Michigan (0.02%), Hartford Investment Management Co. (0.01%) and Bank of Montreal Can (0.01%). Company insiders that own Prestige Brands stock include Gary E Costley, Jean A Boyko, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Institutional Ownership Trends for Prestige Brands.

PBH stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC and Municipal Employees Retirement System of Michigan. View Insider Buying and Selling for Prestige Brands.

PBH stock was purchased by a variety of institutional investors in the last quarter, including Hartford Investment Management Co. and Bank of Montreal Can. Company insiders that have bought Prestige Brands stock in the last two years include Gary E Costley, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Insider Buying and Selling for Prestige Brands.

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PBH stock can currently be purchased for approximately $36.82.

Prestige Brands has a market capitalization of $1.97 billion and generates $1.04 billion in revenue each year. The company earns $339.57 million in net income (profit) each year or $2.58 on an earnings per share basis. Prestige Brands employs 530 workers across the globe.

Prestige Brands' mailing address is 660 WHITE PLAINS ROAD, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]